** Shares in Corbion jump 7%, paring gains after rising as much as 9%, after the Dutch biochemical group posted Q3 results
** The co reported Q3 adjusted EBITDA 49.7 million euros ($57.96 million)and maintained its FY 2025 outlook
** "Management has demonstrated its iron will and determination to maintain its guidance for full year organic EBITDA growth of 25%," says ING
** Broker therefore expects a "record breaking EBITDA" 50.5 million euros in 4Q25
** "We continue to appreciate Corbion for its market leadership in lactic acid and growth opportunities within the existing portfolio," KBC says
** If gains hold, share on track for best day since March 2024
($1 = 0.8575 euros)
(Reporting by Dimitri Rhodes)
((Dimitri.rhodes@thomsonreuters.com))